Therapeutic Implications of GIPC1 Silencing in CancerThomas W. Chittenden(Dana-Farber Cancer Institute), John Quackenbush(Harvard University)PLoS ONEDecember 30, 201010.1371/journal.pone.0015581Cited by 28SaveCiteExport RISWatch citationsRelated PapersTranscriptional Profiling in Coronary Artery Disease|Circulation|2006|53